- Home
- HUBG vs CLDX Comparison
HUBG vs CLDX Comparison
Compare HUBG & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HUBG | CLDX |
|---|---|---|
| Founded | 1971 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.6B |
| IPO Year | 1996 | 1995 |
Fundamental Metrics
Financial Performance| Metric | HUBG | CLDX |
|---|---|---|
| Price | $44.83 | $37.65 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 10 |
| Target Price | $42.83 | ★ $46.60 |
| AVG Volume (30 Days) | 741.0K | ★ 1.2M |
| Earning Date | 05-12-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.17% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.34 | N/A |
| Revenue | ★ $3,946,390,000.00 | $12,743,000.00 |
| Revenue This Year | N/A | $111.39 |
| Revenue Next Year | $2.88 | $235.85 |
| P/E Ratio | $33.42 | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $32.46 | $19.72 |
| 52 Week High | $53.26 | $39.16 |
Technical Indicators
Market Signals| Indicator | HUBG | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 57.22 | 72.44 |
| Support Level | $34.77 | $28.51 |
| Resistance Level | $46.81 | N/A |
| Average True Range (ATR) | 1.34 | 1.54 |
| MACD | -0.09 | 0.63 |
| Stochastic Oscillator | 53.43 | 82.54 |
Price Performance
Historical ComparisonAbout HUBG Hub Group Inc.
Hub Group ranks among the largest providers of rail intermodal service. Approximately 60% of consolidated revenue comes from Hub's intermodal and transportation solutions division. ITS includes its flagship intermodal operations, which use the Class I rail carriers for the underlying line-haul movement of containers, as well as its dedicated truckload shipping unit. Hub's logistics segment includes its asset-light truck brokerage operations along with its outsourced transportation management, warehousing and fulfillment, and heavy-goods final mile delivery offerings. Hub often makes tuck-in acquisitions that expand its brokerage, last-mile, and dedicated offerings.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.